BNVA 150 Pill - white oval, 14mm
Generic Name: ibandronate
Pill with imprint BNVA 150 is White, Oval and has been identified as Boniva 150 mg. It is supplied by Roche Laboratories.
Boniva is used in the treatment of Prevention of Osteoporosis; Osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BNVA 150
Boniva
- Generic Name
- ibandronate
- Imprint
- BNVA 150
- Strength
- 150 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- Inactive Ingredients
-
lactose monohydrate,
povidone k25,
microcrystalline cellulose,
stearic acid,
silicon dioxide,
titanium dioxide,
magnesium silicate,
polyethylene glycol 6000
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00004-0186 (Discontinued) | Roche |
| 54868-5322 (Discontinued) | Physicians Total Care Inc. (repackager) |
| 35356-0423 | Lake Erie Medical and Surgical Supply (repackager) |
More about Boniva (ibandronate)
- Check interactions
- Compare alternatives
- Reviews (98)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: bisphosphonates
- Breastfeeding
- En español
Patient resources
- Boniva drug information
- Boniva (Ibandronate Intravenous) (Advanced Reading)
- Boniva (Ibandronate Oral) (Advanced Reading)
- Boniva (Ibandronate Injection)
- Boniva (Ibandronate Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
